两种不同的免疫细胞特征可预测无肌病性皮肌炎合并间质性肺病患者的临床结局
研究对82例无肌病性皮肌炎合并间质性肺病(ADM-ILD)患者和82名年龄性别匹配的健康供者外周血42种免疫细胞表型行多色流式细胞术检测,用无监督层次聚类将患者分为2个集群;集群1富集活化CD45RA+HLA-DR+CD8+T细胞且CD56dim自然杀伤细胞比例降低,快速进展性间质性肺病(RPILD)患病率更高、死亡率更高;集群2(非活化T细胞主导)临床结局良好、生存率高;免疫表型是与1年生存相关的独立危险因素。
要点
- 82例ADM-ILD患者外周血42种免疫细胞表型经层次聚类分为2个与疾病活动度和临床结局相关的集群。
- 集群1富集活化CD45RA+HLA-DR+CD8+T细胞、CD56dim自然杀伤细胞比例降低,RPILD患病率和死亡率更高。
- 集群2为非活化T细胞主导,临床结局良好、生存率高;免疫表型为1年生存的独立危险因素。
核心结论
- 外周免疫特征可能有助于按疾病严重程度和临床结局对ADM-ILD患者进行分层,可能对结局预测、发病机制研究和治疗选择有意义。
研究设计与样本
- 研究纳入82例ADM-ILD患者和82名年龄、性别匹配的健康供者,用多色流式细胞术评估外周血42种免疫细胞表型。
- 采用无监督机器学习方法(层次聚类分析)按免疫细胞亚群对患者进行分层。
- 采用多重Wilcoxon符号秩检验和有监督机器学习方法识别重要免疫细胞亚群。
- 采用Kaplan-Meier生存分析及log rank检验绘制生存曲线。
主要发现
- 在ADM-ILD中识别出2个与不同疾病活动度和临床结局相关的集群。
- 集群1富集活化CD45RA+HLA-DR+CD8+T细胞,CD56dim自然杀伤细胞比例降低,RPILD患病率更高且死亡率更高。
- 集群2为非活化T细胞主导的集群,临床结局良好、生存率高。
- 免疫表型是与1年生存相关的独立危险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Amyopathic dermatomyositis (ADM) is a heterogeneous and life-threatening autoimmune disease with a high mortality rate. In particular, anti-melanoma differentiation-associated protein 5 antibody-positive patients are at a high risk of developing rapidly progressive interstitial lung disease (RPILD). This study was undertaken to identify immunologic signatures among patients who have ADM with ILD (ADM-ILD) and to discover the biomarkers predicting prognosis. METHODS: The landscape of 42 immune cell phenotypes in the peripheral blood of 82 ADM-ILD patients and 82 age- and sex-matched healthy donors was assessed by multicolor flow cytometry. Patients were stratified using an unsupervised machine learning method (hierarchical clustering analysis) by immune cell subsets. Multiple Wilcoxon's signed rank tests and supervised machine learning methods were performed to identify important immune cell subsets. Kaplan-Meier survival analysis with log rank tests was used to create survival curves. RESULTS: We identified 2 distinct clusters correlating with different disease activities and clinical outcomes in ADM-ILD. Cluster 1 was enriched in the activated CD45RA+HLA-DR+CD8+ T cells with decreased CD56dim natural killer cell proportions and showed a higher prevalence of RPILD and higher mortality. In contrast, the other subgroup, cluster 2 (the nonactivated T cell-dominant cluster), displayed favorable clinical outcomes with high survival rates. Our data also revealed that immunophenotype was an independent risk factor associated with 1-year survival. CONCLUSION: Peripheral immunologic features may have the potential to stratify patients with ADM-ILD according to different disease severity and clinical outcomes, which may have implications for outcome prediction, pathogenesis study, and therapy selection.
引用
- Ye Y, Zhang X, Li T, et al. Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyopathic Dermatomyositis With Interstitial Lung Disease. Arthritis Rheumatol. 2022. PMID: 35713981. doi:10.1002/art.42264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。